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Brucella abortus is an intracellular pathogen of monocytes, macrophages, dendritic cells, and placental trophoblasts. This bacte-
rium causes a chronic disease in bovines and in humans. In these hosts, the bacterium also invades neutrophils; however, it fails
to replicate and just resists the killing action of these leukocytes without inducing significant activation or neutrophilia. More-
over, B. abortus causes the premature cell death of human neutrophils. In the murine model, the bacterium is found within mac-
rophages and dendritic cells at early times of infection but seldom in neutrophils. Based on this observation, we explored the
interaction of mouse neutrophils with B. abortus. In contrast to human, dog, and bovine neutrophils, naive mouse neutrophils
fail to recognize smooth B. abortus bacteria at early stages of infection. Murine normal serum components do not opsonize
smooth Brucella strains, and neutrophil phagocytosis is achieved only after the appearance of antibodies. Alternatively, mouse
normal serum is capable of opsonizing rough Brucellamutants. Despite this, neutrophils still fail to kill Brucella, and the bacte-
rium induces cell death of murine leukocytes. In addition, mouse serum does not opsonize Yersinia enterocoliticaO:9, a bacte-
rium displaying the same surface polysaccharide antigen as smooth B. abortus. Therefore, the lack of murine serum opsoniza-
tion and absence of murine neutrophil recognition are specific, and the molecules responsible for the Brucella camouflage are
N-formyl-perosamine surface homopolysaccharides. Although the mouse is a valuable model for understanding the immunobi-
ology of brucellosis, direct extrapolation from one animal system to another has to be undertaken with caution.
Polymorphonuclear neutrophil leukocytes (PMNs) are the firstline of defense of the innate immune system. These cells detect
microbial structures through various receptors, and the recogni-
tion of these structures influences their activation and fate, which
are essential to promote inflammatory responses and host defense
mechanisms.
Brucellosis is a chronic disease of domestic and wildlife mam-
mals and a worldwide human zoonosis caused by Brucella species
(1).Members of this genus are intracellular pathogens that invade
monocytes (Mo), macrophages (M), and dendritic cells (DCs),
as well as placental trophoblasts (1). Although in the natural host
and in humans Brucella also invades PMNs (2–4), the bacterium
fails to replicate in these cells and just resists their killing action
without inducing significant activation (3–6). Indeed, Brucella-
infected PMNs do not degranulate and induce low levels of reac-
tive oxygen species (ROS) and cytokines, and the infection follows
its course without significant neutrophilia (5, 7, 8). Likewise, the
PMNs infiltration of the cervical lymph nodes after oral infection
is very low, even in well-developed granulomas after 15 days of
infection (9). Moreover, after 5 days of infection, the bacterium is
foundwithinM andDCs ofmice but seldom inside PMNs in the
target organs (10). In addition, the absence of PMNs during bru-
cellosis promotes the activation of the Th1 adaptive immune re-
sponse (11).More significantly,Brucella is capable of inducing the
premature cell death of human PMNs bymeans of its lipopolysac-
charide (Br-LPS) through a mechanism that involves CD14 and
mild NADPH oxidase activation (6). This has led to the proposal
that Brucella-infected PMNs function as “Trojan horses” after
nonphlogistic phagocytosis byM andDCs. This would favor the
spread of bacteria to different organs, fostering the chronicity of
the disease (6).
The mouse has been the preferred animal model in brucellosis
research to test and evaluate different hypotheses (12, 13). Here,
we have explored the interaction of naive mouse PMNs with Bru-
cella abortus and found that these cells fail to recognize this bacte-
rium in the absence of antibodies. This is significant since the
outcome of brucellosis in a given animal species may be deter-
mined during the initial stages of the infection that influence the
downstream events of the immune response.
MATERIALS AND METHODS
Ethics. Experimentation in mice was conducted with the consent of and
according to guidelines established by the ‘Comité Institucional para el
Cuido y Uso de los Animales de la Universidad de Costa Rica (CICUA-
47-12) and in accordance with the corresponding law, Ley de Bienestar de
los Animales, of Costa Rica (Law 7451 on Animal Welfare). Mice were
accommodated in the animal building at the Veterinary Medicine School
of the National University, Costa Rica. All animals were kept in cages with
food and water ad libitum under biosafety containment conditions, pre-
vious to and during the experiment. Blood from roaming dogs kept at the
shelter of the Hospital of the Veterinary Medicine School of the National
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University, Costa Rica, was taken for routine diagnostic purposes, accord-
ing to the respective consent and approval (SIA 0434-14) and the guide-
lines established by the Ley de Bienestar de los Animales of Costa Rica
(Law 7451 on Animal Welfare).
Human blood samples were collected from volunteer donors at the
Tropical Disease Research Program (PIET), of the National University,
Costa Rica, according to the corresponding institutional approval (SIA
0248-13). Accordingly, volunteers were carefully informed regarding the
study and provided written consent. Samples were taken following the
procedures dictated by theCosta RicanNationalHealth system (Ley 9234,
Costa Rica, La Gaceta 79, 2014) and by the World Medical Association
(WMA) Declaration of Helsinki (59th WMA General Assembly, Seoul,
October 2008), regarding the use of blood samples.
Experimental animals. Wild-type Mus musculus animals were cap-
tured from the grounds of the university campus of the National Univer-
sity, Costa Rica. C57BL/6, BALB/c, and CD-1 mice (18 to 21 g) were
provided by the following animal facilities: Instituto Clodomiro Picado,
University of Costa Rica; School of Veterinary Medicine, National Uni-
versity, Costa Rica; and Laboratorio de Ensayos Biológicos, University of
Costa Rica.
Bacterial strains and Br-LPS preparations. Virulent B. abortus 2308,
B. abortus 2308 wadC, B. abortus 2308 per (14), B. abortus 2308 ex-
pressing green fluorescent protein (B. abortus 2308-GFP) (15), transgenic
B. abortus 2308 with an integrated chromosomal gene coding for the red
fluorescent protein (B. abortus 2308-RFP) from Discosoma coral (pro-
vided by Jean-Jacques Letesson, Unité de Recherche en Biologie Molécu-
laire, Facultés Universitaires Notre-Dame de la Paix, Namur, Belgium),
Yersinia enterocoliticaO:9 (16), Staphylococcus aureus (ATCC 25923), and
Escherichia coli (ATCC 25922) were grown in tryptic soy broth as previ-
ously described (15). Purified Br-LPS suspensions were prepared from B.
abortus 2308, as reported elsewhere (17).
Immunization and immune serum production against B. abortus.
C57BL/6 and CD-1 mice were intraperitoneally infected with 0.1 ml of
phosphate-buffered saline (PBS) containing 106 CFU of virulent B. abor-
tus 2308 bacteria.Mice were bled at different times, and antibody titration
was carried out by microagglutination in 96-well round-bottom plastic
plates. Briefly, Rose Bengal antigen was diluted 1/20 in PBS and used as a
bacterial suspension for agglutination.Volumes of 50l of serumdilution
were added to 50l of antigen suspension. Samples were incubated at 4°C
for 24 h, and bacterial agglutination was recorded in the bottom of the
plate. Agglutination titers beyond 1/50 were considered positive.
For immune serum production, mice were infected as described
above; after 30 days of infection mice were bled, and serumwas separated
by centrifugation and filtered through a 0.2-m-pore-size membrane
(Millipore). Serum was then stored at20°C in aliquots. IgGs were puri-
fied from immune mouse serum as reported elsewhere (18). Western
blotting of mouse immune serum revealed that most of the antibody
recognition was directed against Br-LPS (16). For ex vivo opsonization
experiments, subagglutinating doses of antibodies were added to each
well. In all experiments nonimmune mouse immunoglobulins were used
as controls and administered at the same concentrations as the specific
antibodies.
Bone marrow-derived PMNs. Murine bone marrow cells were iso-
lated essentially as described byBoxio et al. (19). Briefly, bonemarrowwas
collected from the femurs and tibiae of BALB/c mice and suspended in 1
ml of Hanks’ balanced salt solution (HBSS; no calcium and no magne-
sium) containing 2 mM EDTA and 2% inactivated fetal calf serum. After
samples were washed once with 2 ml of HBSS, cell concentration was
determined with a Neubauer chamber, and the PMN percentage was cal-
culated by Giemsa staining after cytospin centrifugation (Shandon Cyto-
spin 2) or by flow cytometry using Guava easyCyte (Millipore). Data were
analyzed with FlowJo software, version 10.0.7 (Tree Star, Inc.), as de-
scribed previously (6). For some experiments, direct observation of spleen
cells from B. abortus 2308-GFP-infectedmice was performed as described
elsewhere (20).
PMN phagocytosis assay. Aliquots of 350 l of human, canine, or
murine fresh heparinized blood were incubated with bacteria or2-m
latex beads (Sigma-Aldrich) at 37°C for 1 h under mild agitation, at the
multiplicity of infection (MOI) indicated in the figure legends. Alterna-
tively, bone marrow-derived mouse PMNs suspended in 350 l HBSS or
mouse serum were incubated with bacteria at 37°C for 1 h under mild
agitation, at theMOI indicated in the figure legends. Blood smears in three
glass slides were fixed with methanol, centrifuged in a cytospin, mounted
with ProLong Gold Antifade reagent with 4=,6=-diamidino-2-phenylin-
dole (DAPI; Thermo Fisher Scientific), and observed under a fluorescence
microscope. Before cell staining on glass slides, bone marrow cell suspen-
sions were fixed with BD fluorescence-activated cell sorter (FACS) lysing
solution or 3.5% paraformaldehyde. At least 50 PMNs were counted per
slide, and the number of intracellular fluorescent bacteria/PMN was de-
termined.
Ex vivo bactericidal activity of serum and PMNs.Bacteria (105 to 106
CFU)were incubatedwith 350l of normal, heat-inactivated (56°C for 30
min), and yeast-consumed and -inactivated (37°C for 1 h) serum or with
immune mouse serum at 37°C at different times. After incubation, ali-
quots were dispersed on Trypticase soy agar plates and incubated at 37°C
for 48 to 72 h, and CFU counts were determined. Aliquots of 350 l of
fresh mouse heparinized blood or bone marrow PMNs (suspended in
HBSS or mouse serum) were mixed at an MOI of 2 or 5 bacteria/PMN
undermild agitation at 37°C for up to 90min. In some cases the bloodwas
supplemented with 0.25% anti-Brucella murine immune serum. After
incubation, cells were lysed with 0.2% Triton X-100 and 1,000 U/ml
DNase (Sigma); aliquots were dispensed on Trypticase soy agar plates and
incubated at 37°C for 48 to 72 h, and CFU counts were determined.
PMN cell death assays. Aliquots of 350 l of fresh human or mouse
heparinized blood were mixed with different concentrations of B. abortus
orBr-LPSundermild agitation at 37°C for 2 h. After incubation, red blood
cells were lysed bymixing 100l of heparinized bloodwith 1,500l of red
blood cell lysis buffer (8.02 g ofNH4Cl, 0.84 g ofNaHCO3, and 0.37 g/liter
EDTA, pH 7.2) for 5 min. Then the remaining leukocytes were washed
with ice-cold PBS to remove cell debris and resuspended in 100 l of
annexin V binding buffer (Life Technologies). Volumes of 5l of annexin
V and 2l of AquaDead (Invitrogen) diluted 1/20 in PBS were added and
incubated for 30 min on ice in the dark. Cells were washed once with
ice-cold PBS and resuspended in 500 l of BD FACS lysing solution.
Samples were then subjected within 1 h to flow cytometry analysis using
Guava easyCyte (Millipore), and data were analyzed using FlowJo soft-
ware, version 10.0.7 (Tree Star, Inc.), as described previously (6).
Adsorption of serum components by B. abortus and protein identi-
fication. For serum adsorption, 5  1010 CFU of the corresponding B.
abortus strain was incubated with 3ml ofmurine or human serum at 37°C
for 45 min under mild agitation. Control bacteria were incubated with
only PBS, pH 7.2. Bacteria were washed four times with PBS, pH 7.2. All
bacterial preparations were treated with 0.1 M glycine-HCl (pH 2.7) to
remove adsorbed proteins or with PBS for control purposes. The eluted
supernatants were neutralized with 1MTris-HCl (pH 9) and precipitated
with methanol-chloroform. Samples were subjected to 10% SDS-PAGE
under reducing conditions. The Coomassie blue-stained protein bands
were excised and subjected to reduction, alkylation, and in-gel tryptic
digestion, followed by matrix-assisted laser desorption ionization–two-
stage time of flight (MALDI-TOF-TOF) mass spectrometry analysis on a
Proteomics Analyzer 4800 Plus mass spectrometer (Applied Biosystems),
as described elsewhere (21). Resulting fragmentation spectra were
searched against the corresponding mouse or human UniProt databases
(www.uniprot.org) using ProteinPilot, version 4.0, and the Paragon algo-
rithm (ABsciex) for protein identification at95% confidence.
Complement and fibronectin detection. For Western blotting, sam-
ples were transferred to a polyvinylidene difluoride (PVDF) membrane
after SDS-PAGE. The membranes were blocked and incubated for the
detection of murine complement C3 with 1:500 diluted goat anti-mouse
C3 antibody (Thermo Scientific) and further with 1:1,000 protein G-per-
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oxidase (Life Technologies). For the detection of murine fibronectin,
membranes were incubated with 1:500-diluted goat IgG anti-fibronectin
antibodies (Sigma) and further with 1:1,000 protein G-peroxidase (Life
Technologies). Proteinswere detectedwith enhanced chemiluminescence
(Roche).
Statistics. Analysis of variance (ANOVA) or Student’s t test was used
to determine statistical significance in the different assays (JASP Software,
2015 [https://jasp-stats.org/]). Data were processed in Microsoft Office
Excel 2013.
RESULTS
B. abortus is not recognized by naive murine PMNs. We have
previously shown thatB. abortus is phagocytized by human PMNs
and induces the premature death of these leukocytes through the
action of its LPS (6). This has led to the hypothesis that infected
PMNs function as Trojan horses that spread the Brucella infection
in different organs (6). Based on this, we asked whether B. abortus
and its LPS could induce the same effect in murine PMNs. As
shown in the experiment presented in Fig. 1, while human
PMNs died after contact with B. abortus or its LPS, mouse
PMNs did not show any signs of cell death after exposure to
these components.
In order to understand this phenomenon,we then explored the
early interaction ofmurine PMNswithB. abortus and compared it
with that of PMNs of other animals. It has been shown that naive
mouse PMNs readily ingest S. aureus and E. coli in the presence or
absence of complement opsonization (22, 23). In agreement with
this, we also observed phagocytosis of S. aureus and E. coli by
PMNsof an outbredCD-1 strain andwildMusmusculus (Fig. 2A).
Likewise, human and dog PMNs readily ingested these two bacte-
rial species. In contrast to PMNs of humans and dogs, murine
PMNs failed to ingestB. abortus (Fig. 2A). Phagocytosis ofBrucella
bymurine PMNswas seldomdetected even at a highMOI (100).
Moreover, at this concentration, some bacteriamay remain on the
cell surface and not be internalized (Fig. 2B). The absence of Bru-
cella recognition was specific since murine PMNs were capable of
ingesting not only other bacteria but also large numbers of latex
beads (Fig. 2B). Similar observations were obtained with PMNs
from inbred C57BL/6 (Fig. 2B) and BALB/cmice. Consistent with
previous results (5), B. abortus was isolated from the blood of
infected mice as early as 1 h after infection, and bacteremia per-
sisted for at least 2 days. In spite of this, we did not detect Brucella-
infected PMNs in blood or in target organs during the first 4 days
of infection, corroborating previous results (10).
Altogether these results demonstrate that the interaction of
murine PMNs with B. abortus significantly departs from that of
PMNs fromhumans, guinea pigs, cows, goats, and dogs, which are
capable of phagocytizing Brucella in the absence or presence of
complement (3, 4, 24–26).
Mouse PMNs ingest B. abortus after the development of
adaptive immunity. Antibodies are well-known opsonizing ele-
ments. We then explored the ability of murine PMNs to phagocy-
tize B. abortus during development of the adaptive immune re-
sponse. At the onset of infection (first 2 days) Brucella was not
internalized by murine PMNs (Fig. 3A); however, at later times
the bacterium was readily phagocytized by these leukocytes (Fig.
3A). This internalization correlated with a quick rise in murine
antibodies against Br-LPS (the main Brucella antigen) (27). Both
immune mouse serum and specific IgG anti-Brucella promoted
the phagocytosis of B. abortus by murine PMNs (Fig. 3B and C).
As indicated previously (5), under the microscope, these in-
FIG 1 B. abortus and its LPS do not induce the cell death of mouse PMNs. (A) Heparinized blood of humans or C57BL/6 mice was incubated with B. abortus
2308-GFP at the indicated MOI for 2 h, and the PMN population was gated and analyzed by cytometry using annexin V as a cell death marker. (B) Heparinized
blood of C57BL/6 mice was incubated with B. abortus 2308-GFP at an MOI of 10 (green line) or an MOI 100 (blue line) or with PBS (red line) for 2 h, and the
PMNpopulationwas gated and analyzed by cytometry using annexin V as a cell deathmarker. (C)Heparinized blood of humans or C57BL/6mice was incubated
with Br-LPS at the indicated concentrations for 2 h, and the PMN population was gated and analyzed by cytometry for cell death markers using AquaDead and
annexin V. The proportions of PMNs positive for the respective marker are presented with each section of the corresponding cytogram. While human PMNs
acquire death cell markers, mouse PMNs remain unaffected. The figure represents one experiment of at least four repetitions.
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fected leukocytes did not show obvious signs of alterations at
early times of infection (1 h). These results indicate that
phagocytosis of B. abortus by murine PMNs is efficiently medi-
ated by opsonizing antibodies through Fc receptors at the sur-
face of these leukocytes.
Surface N-formyl-perosamine homopolysaccharides are re-
sponsible for Brucella camouflage. Since innate mouse opsonins
failed to promote the phagocytosis of smooth B. abortus by mu-
rine PMNs, we then explored the presence of blocking compo-
nents on the bacterial surface. First, we tested the ability ofmurine
PMNs to phagocytize the roughB. abortus 2308permutant lack-
ing surfaceN-formyl-perosamine sugars (Br-LPSO chain and na-
tive hapten [NH] polysaccharide) and the smooth B. abortus 2308
wadC mutant displaying a defect in the core oligosaccharide
(Fig. 4). While the core wadC mutant was not recognized by
murine PMNs and behaved as the parental strain did, the rough
per mutant was readily phagocytized in the presence of normal
but not inactivated mouse serum (Fig. 5A). High numbers of in-
tracellular rough B. abortus per bacteria did not cause obvious
alterations inmouse PMNs at early times (1 h) of infection (Fig.
5A, inset), paralleling the results obtained with antibody-op-
sonized smooth brucellae (Fig. 3C).
To confirm the role ofN-formyl-perosamine sugars in theBru-
cella camouflage, we then tested the phagocytosis of Yersinia en-
terocolitica O:9. The O chain and NH surface molecules of this
bacterium are identical to those of B. abortus (16, 28). Y. enteroco-
liticaO:9was not phagocytized bymouse PMNs in the presence of
normal mouse serum (Fig. 5B). However, this bacterium was
readily internalized in the presence of anti-Brucella antibodies.
These results demonstrate that the surface N-formyl-perosamine
polysaccharides were the moieties responsible for the B. abortus
camouflage for opsonization.
B. abortus is resistant to the bactericidal action of mouse
immune serum and PMNs. Since it has been shown that B. abor-
tuswadC andpermutants aremore sensitive to the bactericidal
action of bovine serum than the parental strain (14), we then
asked whether murine serum components and PMNs were capa-
ble of killing intracellular Brucella. The wadCmutant was resis-
tant to the action of normal mouse serum, as was the virulent B.
abortus 2308 strain (Fig. 5C). Moreover, the presence of anti-Bru-
cella antibodies did not have a significant effect on the viability of
FIG 2 Naivemurine PMNs do not phagocytizeB. abortus. (A) Blood from the indicated species was incubatedwithB. abortus-GFP, S. aureus, or E. coli at anMOI
of 20 for 1 h. Blood smears were then fixed and mounted with ProLong Gold Antifade reagent with DAPI. At least 50 PMNs were counted per sample, and the
number of intracellular bacteria in each PMN and the proportion of phagocytosis were estimated under fluorescence microscopy. (B) Comparison between
C57BL/6mouse PMNs incubatedwithB. abortus 2308-RFP at anMOI of 100, humanPMNs incubatedwithB. abortus-GFP at anMOI of 50, andGiemsa staining
of C57BL/6mouse PMNs incubated with latex beads at anMOI of 100, as indicated.Magnifications,200 (frame a) and400 (frames b and c). Images were cut
from the microscope field, contrasted, and saturated using the hue tool to obtain suitable color separation. Similar results were obtained with BALB/c mice.
FIG 3 Mouse PMNs phagocytizeB. abortus after antibodies are generated. CD-1
mice were infected intraperitoneally with 106 CFU; then, mouse blood was col-
lected at different days of infection and incubatedwithB. abortus 2308-RFP (MOI
of 50) for 1 h. Blood smears were then fixed and mounted with ProLong Gold
Antifade reagent with DAPI. At least 50 PMNs were counted per sample, and the
number of intracellular bacterial in each PMN was determined. The relative ag-
glutination titer for the day evaluated after intraperitoneal injection with B. abor-
tus is indicated at the top of the bars according to the legend on the figure. (B)
Mouse PMNs of CD-1mice were incubatedwithB. abortus 2308-RFP at anMOI
of 50 for 2 h and under different conditions of opsonization. Then, the number of
phagocytizedbacteriawas recordedbyfluorescencemicroscopy. (C)CD-1mouse
PMNs incubated with B. abortus 2308-RFP and anti-Brucellamouse serum at an
MOI of 100. The image was cut from the microscope field, contrasted, and satu-
rated using hue tool to obtain suitable color separation (magnification, 200).
Similar results were obtained with C57BL/6 and BALB/c mice.
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the bacteria (Fig. 5C). Although serumcomponents opsonized the
rough per mutant, no bactericidal activity was recorded by
mouse serum in the absence or presence of PMNs (Fig. 5D).
N-Formyl-perosamine homopolysaccharides hamper the
binding of murine heat-labile serum components. Since bacte-
rial opsonization commonly occurs via activation and binding of
various heat-labile serum factors such as complement and fi-
bronectin (29), we then asked whether B. abortus was capable of
interacting with these components. As presented in Fig. 6A, B.
abortus was capable of adsorbing a significant number of human
serum proteins, including complement components. Under the
same experimental conditions mouse serum constituents were
barely adsorbed by smooth or rough B. abortus strains (Fig. 6A).
The small amounts of mouse serum proteins adsorbed by B. abor-
tus strains, revealed as faint bands, corresponded to serum albu-
min, platelet factor 4, and mannose binding protein. With the
exception of the last protein, no other opsonins or complement-
related proteins were detected by this proteomic approach.
In spite of the overall lack of affinity of the Brucella cell enve-
lope for mouse serum factors, it was revealed byWestern blotting
that the per mutant adsorbed heat-labile complement and fi-
bronectin in larger amounts than the smooth counterpart strain
2308 (Fig. 6B). This was consistent with the phagocytosis of B.
abortus per by murine PMNs in the presence of normal but not
inactivated serum (Fig. 5A). These results demonstrate that
phagocytosis of the per strain by murine PMNs occurs through
opsonization of small amounts of heat-labile serum components
such as complement and fibronectin and that theO chain andNH
polysaccharides hamper the access of these components to surface
bacterial molecules.
Intracellular B. abortus induces the cell death of mouse
PMNs.We have demonstrated that B. abortus induces premature
cell death of human PMNs (6). Therefore, we explored the effect
of both the antibody-opsonized smooth B. abortus 2308 and the
rough mutant B. abortus per on mouse PMNs. As shown in Fig.
7, both internalized bacteria readily induce the cell death of mu-
rine PMNs, paralleling the phenomenon observed with human
PMNs.
DISCUSSION
It has been shown that naive human, guinea pig, bovine, rat,
caprine, and canine PMNs readily phagocytize both smooth and
rough Brucella species (3–5, 24–26, 30). Moreover, PMNs from
some of these animals (humans, guinea pigs, rats, and cows) are
capable of ingesting Brucella in the presence of inactivated normal
serum or even in the absence of serum (3, 4, 6). In general, the
overall behavior of humanPMNs is rather similar to that observed
with bovine PMNs (4), a phenomenon that is commensurate with
the coevolution of B. abortus and its host.
In this work we have shown thatmouse normal serum compo-
nents do not opsonize smooth B. abortus and that mouse PMNs,
in the absence of specific antibodies, do not phagocytize this bac-
terium. This phenomenon is specific, and the molecules respon-
sible for the Brucella camouflage are N-formyl-perosamine sur-
face homopolysaccharides (Fig. 4). This is relevant since in
addition to the hindrance function, these perosamine polysaccha-
FIG 4 Schematic structure of B. abortus outer membrane showing the LPS and NH. The O polysaccharide and native hapten (NH) are unbranched linear
homopolymers of 	-1,2-linked 4,6-dideoxy-4-formamido-D-mannopyranosyl units (N-formyl-perosamine) with an average chain length of 96 to 100 glycosyl
subunits (28). While the NH is not directly bound to the lipid membrane, the O polysaccharide is linked to a core bifurcating oligosaccharide composed of

GlcN-6-
GlcN-4-
GlcN(-6-
GlcN)-3-	Man(-6-	Glc)-5-KDO1(1-KDO1)-lipid A immersed in the outer membrane. Branching from KDO2 is 	PerNFo-
(-2PerNFo)n-2PerNFo-2-	Man-3-	Man-3-
QuiNAc-4-
Glc-4-KDO2-4-KDO2 (59). The KDO1 is linked to the lipid A composed of a backbone of diamino-
glucose (DAG) disaccharide, substituted with phosphates (P) and amide and ester-linked long-chain saturated (C16:0 to C18:0) and hydroxylated (3-OH-C12:0 to
29-OH-C30:0) fatty acids (17, 60). The lipid A is bound to the outer membrane. KDO, ketodeoxyoctulosonic acid; Man, mannose; QuiN, acetyl-quinovosamine;
Glc, glucose (Glc); PerNFo, N-formyl-perosamine. The wadC mutation precludes the incorporation of the 
GlcN-6-
GlcN-4-
GlcN(-6-
GlcN)-3-	Man
(-6-	Glc)-oligosaccharide to the KDO1 (marked by a gray area) while the per mutation precludes the incorporation of 	PerNFo-(-2PerNFo)n-2PerNFo-
homopolymer (61).
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rides display other biological properties related to virulence, such
as dimerization ofmajor histocompatibility complex (MHC) class
II, blocking of MHC class II antigen presentation, and protection
against a collection of bactericidal substances (16, 31–33).
The absence of NH andO-chain polysaccharides uncovers po-
tential targets in the Brucella cell envelope, such as outer mem-
brane proteins and phospholipids, as well as ketodeoxyoctu-
losonic acid (KDO) and lipid A phosphate groups, present in the
innermost sections of the coremoiety (14, 34). Still, mouse PMNs
fail to ingest the rough B. abortus per mutant in the absence of
classical heat-sensitive serum opsonins, such as complement and
fibronectin. This is relevant since mouse PMNs are capable of
ingesting latex beads and other bacteria, such as S. aureus and E.
coli, in the presence or absence of complement, albeit the phago-
cytosis is more efficient in the former case (22, 23). In the absence
of opsonization by specific antibodies or complement, PMNsmay
FIG 5 Surface N-formyl-perosamine polysaccharides are responsible for Brucella camouflage. (A) Smooth B. abortus wadC and rough per mutants were
incubated with BALB/c bone marrow PMNs at the indicated MOIs in the presence of normal or inactivated mouse serum, and phagocytosis was recorded as
described in the legend of Fig. 2. The inset corresponds to a PMN with internalized B. abortus per (MOI of 50); the infected cell was fixed and mounted with
ProLongGold Antifade reagent with DAPI and observed under the fluorescencemicroscope at amagnification of200. The image was cut from themicroscope
field, contrasted, and saturated using the hue tool to obtain suitable color separation. (B) Y. enterocolitica O:9 (MOI of 100) was incubated with BALB/c bone
marrow PMNs in the presence of normal serum or serum with anti-Brucella antibody (2%), and the phagocytosis was recorded. (C) B. abortus 2308 and the
wadCmutant (106 CFU)were incubatedwith normal or inactivatedmouse serumor normalmouse serum containing antibodies againstBrucella, and bacterial
viability was recorded after 45min of incubation. (D) B. abortusperwas incubated in the presence of normal or inactivatedmouse serum or with BALB/c bone
marrow PMNs in normal serum, and the bacterial viability was estimated at the indicated times.
FIG 6 Normal mouse serum proteins do not opsonize smooth B. abortus. (A) Coomassie blue-stained 10% SDS-PAGE gel of mouse (M) and human (H)
proteins (10g/well) eluted from the surface of B. abortus 2308 or thepermutant after incubation of the respective serumwith viable bacterial cells. Individual
lines, corresponding to the different eluted fractions, were cut out and separated from the main gel as indicated in the figure; then each gel line was horizontally
sliced (about 2-mm slices, from top to bottom), and the identities of proteins in each slice were determined by proteomic analysis. (B)Western blotting ofmouse
proteins (10 g/well) eluted from the surface of B. abortus 2308 or the permutant after incubation of the respective serum with viable bacterial cells. Western
blots were developed with monoclonal antibodies against mouse C=3 or monospecific rabbit IgG anti-fibronectin.
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also ingest microorganisms through the pathways of other PMN
pattern recognition receptor (PRRs), such as 
2 integrins, C-type
lectins, or scavenger or pentraxin receptors (22, 35, 36). This ex-
plains the failure of mouse PMN PRRs to recognize putative B.
abortuspathogen-associatedmolecular patterns (PAMPs), such as
outer membrane lipoproteins, adhesion-like proteins, ornithine-
containing lipids, flagellar structures, and phospholipids, among
the most conspicuous elements on the surface of brucellae, which
in other bacteria are constitutive PAMPs and targets for recogni-
tion (7, 8, 14, 27, 37).
Although Brucella organisms are more resistant than other
Gram-negative bacteria to the killing action of human serum and
PMNs, these components are still able to kill about 20 to 30% of
virulent smooth B. abortus bacteria after 90 min (3–5, 38). This
bactericidal activity is even more conspicuous and efficient in the
case of roughB. abortus bacteria (3). In contrast, both smooth and
rough B. abortus strains were totally resistant to the killing ac-
tions of mouse PMNs and complement even in the presence of
antibodies.
Therefore, it seems that the lack of B. abortus recognition and
the failure to kill this bacterium work on at least three different
levels of the innate immune system: (i) the absence of binding of
natural opsonins to the surface of smooth Brucella bacteria, (ii)
the lack of recognition of putative PAMPs by murine PMN PRRs,
and (iii) the virtually absolute resistance of Brucella to the killing
action of mouse complement—by either the alternative or classi-
cal pathway—and PMNs.
Regarding the interaction of Brucella with human comple-
ment, it has been demonstrated that the bacteria are considerably
more resistant to the killing action of human serum than other
Gram-negative bacteria (5, 39). In spite of this, the binding of
human complement components to the surface of B. abortus was
conspicuous and commensurate with the opsonization of this
bacterium by normal serum. This is in clear contrast to the ab-
sence of opsonization and brucellicidal activity observed by
mouse serum. This is striking since it has been proposed that bac-
terial opsonization by mouse complement is similar to that of
human complement and that the mouse has significant quantities
of complement activity and high serum levels of C3 aswell as other
complement proteins (40). However, genetic and structural dif-
ferences have been demonstrated between human and mouse
complement C3 and C4 components (41). For instance, while
human C3 is readily inhibited by compstatin, mouse C3 is resis-
tant to this compound due to structural differences in amino acid
residues 329 to 534 (42). Likewise, mouse C4 does not have clas-
sical C5 convertase activity due to differences with the human
beta-chain segments of C4 and other regions of themolecule con-
tributing to C5 binding (43).
Although the differences between murine and human surface
PMN PRRs have not been explored in detail, there are some dis-
crete features that may be relevant. While in humans the comple-
ment receptor proteins CR1 and CR2 are two different molecules,
in mouse PMNs, they constitute a single chimeric CR1/CR2 mol-
ecule with different affinities for various complement compo-
nents (44). In addition, the affinity of the G protein-coupled
receptor for the chemoattractant and activator formyl-Met-Leu-
Phe (fMLP) is lower in mouse than in human PMNs (45). Like-
wise, while the human PMN receptor CXCR1 uses as the substrate
CXCL8, the mouse counterpart uses CXCL6 (46). Finally, some
receptors present in mouse PMNs (e.g., the sialic acid receptor
CD33, FcRIIIA, FcRIII, and FcRIV) are absent in humans,
and vice versa (e.g., Toll-like receptor 10 [TLR-10], L-selectin
binding to E-selectin, and FcRIIA) (47–52).
Finally, the almost absolute resistance to the killing action of
mouse complement and PMNs is linked to the absence of activa-
tion of these elements by the putative Brucella PAMPs (5, 7, 8, 14,
27, 37), as well as to the bacterial resistance to the microbicidal
substances of PMNs (33, 34). Regarding this, decreased lytic ac-
tivity of mouse complement in comparison to that of the human
counterpart has been described (53).With respect to PMNs, there
are several differences in microbicidal components between hu-
man and mouse. For instance, mouse PMNs lack defensins (54),
and the functions of several proteases and ROS activation differ
between PMNs of mice and humans (55–57). Whether some of
these differences are related to the absence of Brucella recognition
and killing by murine serum components and PMNs remains to
be investigated.
We have previously shown that Brucella induces premature
death of human PMNs (6). Commensurate with this, B. abortus
also induces the death of these leukocytes once the bacteria have
been internalized via Fc receptors or, in the case of the per mu-
tant strain, via other serum opsonins. As proposed (6), this phe-
nomenon may favor the nonphlogistic removal of infected dying
FIG 7 Induction of mouse PMN cell death after phagocytosis of antibody-
opsonized smooth B. abortus 2308 or the roughpermutant. (A) Heparinized
blood of C57BL/6 mice was incubated with B. abortus 2308-GFP or with B.
abortus 2308-GFP opsonized with antibody (Ab) against Br-LPS at the indi-
cated MOIs for 2 h, and then the PMN population was gated and analyzed by
cytometry using annexin V as a cell death marker. Negative controls were
treated with either PBS or antibody alone. Similar results were observed with
bone marrow-derived PMNs. (B) Bone marrow PMNs of BALB/c mice were
incubated with the rough mutant B. abortusper at anMOI of 50 or with PBS
for 4 h, and the PMN population was gated and analyzed by cytometry using
annexin V as a cell death marker. The figure represents one experiment of at
least four repetitions.
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PMNs by M and DCs, favoring the dispersion of Brucella in the
organism following a Trojan horse effect. In this sense, the prema-
ture death of mouse PMNs parallels that of human PMNs, and
therefore it is a useful model to explore this hypothesis.
The mouse model has provided a substantial body of informa-
tion concerning the pathobiology and immunology of brucellosis
(12, 13). Still, our approach has revealed significant differences
between mice and other hosts in front-line elements of innate
immunity that may have a profound influence on downstream
mechanisms of the immune response. This is not trivial since the
outcome of brucellosis in a given animal species may be deter-
mined during the initial stages of immune recognition. Therefore,
the differences between the immune system of mice and that of
other mammals (58) should prevent us from making direct ex-
trapolations and encourage us to dissect the mechanisms behind
them.
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